ECOR electroCore, Inc.
USHealthcareAs of 2026-10-08
Why ECOR matters now
electroCore, Inc. (ECOR) is a US stock in Healthcare. The latest InvestLog snapshot shows $9.51 with -2.16% on the session and $85.7M in market capitalization; recent performance reads 1-month +42.55% and YTD +87.64%.
The latest financial table shown here is Q1 2026, with revenue of $9.6M, net income of $-5.3M, and EPS of $-0.59. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -9.8%.
The latest indexable market news headline is "electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head Comparison" from Defense World.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Lev Joshua S. filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
-13.26
P/S
2.00
EV/EBITDA
-5.61
DCF Value
$-347.26
FCF Yield
-9.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.2%
Operating Margin
-42.0%
Net Margin
-44.1%
ROE
836.3%
ROA
-99.4%
ROIC
-379.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $9.6M | $-5.3M | $-0.59 |
| Q4 2025 | $9.2M | $-3.0M | $-0.38 |
| FY 2025 | $32.0M | $-14.0M | $-1.65 |
| Q3 2025 | $8.7M | $-3.4M | $-0.40 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.87
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.